Investigational Site Number : 6040004

Lima LIMA 11

0 studies enrolling now · 3 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Primary Progressive Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) — Completed
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early